

PEGylation Technology Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The PEGylation technology market is rapidly expanding, driven by increasing demand for biopharmaceuticals and targeted drug delivery systems. As of 2023, the market size is estimated to be over $300 million, with a projected compound annual growth rate (CAGR) of around 10% through the next five years, reflecting robust growth prospects. Request Sample Report
◍ Nektar Therapeutics
◍ Enzon Pharmaceutical
◍ BroadPharm
◍ NOF
◍ Dr. Reddy
◍ SunBio
◍ Creative PEGWorks
◍ Vector Laboratories
◍ Iris Biotech
◍ Biopharma PEG Scientific
◍ Sinopeg
◍ Chemgen Pharma
The PEGylation Technology Market features companies like Nektar Therapeutics, Enzon Pharmaceuticals, and BroadPharm, enhancing drug solubility and stability. They drive market growth through innovative PEGylation solutions. Sales revenues include:
- Nektar Therapeutics: $200 million
- Enzon Pharmaceuticals: $100 million
- Creative PEGWorks: N/A (private company)
Request Sample Report
◍ Protein Drugs
◍ Peptide Drugs
◍ Small Molecule Drugs
◍ Nucleic Acid (Gene) Drugs
◍ Sales of PEG and Derivative Products
◍ Pharmaceutical Sales
◍ Technology Licensing and Product Transfer
Request Sample Report
Request Sample Report
$ X Billion USD